Hep C drugs Hep C drugs

In two recent clinical trials of Harvoni and Sovaldi in the treatment of young people between the ages of 12 and 17, the drugs eliminated all traces of the hepatitis C virus in 97 to 100 percent of patients, generally in 12 weeks. Lloyd Fox/Baltimore Sun/TNS via Getty Images hide caption

toggle caption
Lloyd Fox/Baltimore Sun/TNS via Getty Images

Gilead Sciences Inc. makes the two leading drugs that can quickly cure hepatitis C infections. But most patients can't afford the expensive drugs, and states restrict their use among Medicaid patients. David Paul Morris/Bloomberg via Getty Images hide caption

toggle caption
David Paul Morris/Bloomberg via Getty Images

Should The U.S. Government Buy A Drug Company To Save Money?

  • Download
  • <iframe src="https://www.npr.org/player/embed/520430944/520576934" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript